Please use this identifier to cite or link to this item:
http://hdl.handle.net/2080/4225
Title: | Development of Anti-Amyloidogenic Short-Synthetic Peptides, Rationally Designed Using a Sequence-Based Strategy |
Authors: | Mitra, Amit Sarkar, Nandini |
Keywords: | Amyloidosis Hen egg-white lysozyme peptide inhibitors amyloid inhibition |
Issue Date: | Dec-2023 |
Citation: | 92nd Annual Meet of the Society of Biological Chemists(SBC) BITS Pilani, 18-20th Dec 2023 |
Abstract: | An effective therapeutic strategy for the treatment of amyloidosis is the use of rationally-designed sequence-based short peptide for the inhibition of highly-organized cross-β-sheet predominating aggregates of misfolded amyloidogenic proteins. In this context, we investigated the anti-amyloidogenic potency of a hexapeptide (Tyr-Pro-Gln-Ile-Pro-Asn) on hen egg-white lysozyme (HEWL) amyloid formation at pH 2.2 and pH 7.5 using molecular docking techniques alongside an array of biophysical methodologies including fluorescence spectroscopy, UV-vis spectroscopy, FTIR spectroscopy, CD spectral analysis, confocal laser microscopy and transmission electron microscopy. The peptides, referred to as SqPs (Sequence-based Peptides) was meticulously designed based on the aggregation-prone region (APR) of HEWL. Notably, SqP1, amongst the others, exhibited a remarkable lysozyme amyloid inhibition rate of over 70% and ~50% at pH 2.2 and pH 7.5. Our proposed mechanism suggests that SqP1 engages with the APR of HEWL, establishing robust interactions with Trp62/Trp63 residue in the APR region of HEWL. This strong interaction imparted a stabilizing effect on the monomeric structure of HEWL at both the pH conditions, hindering conformation changes in the protein, and consequently restricts the formation of amyloidogenic fibrils. A sequence-based peptide inhibitor targeting lysozyme amyloid formation has not been documented previously. Thus, our findings hold significant implications, underscoring the pivotal role of rationally-designed synthetic peptides as potent amyloid inhibitors. |
Description: | Copyright belongs to proceeding publisher |
URI: | http://hdl.handle.net/2080/4225 |
Appears in Collections: | Conference Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2023_SBC_AMitra_Development.pdf | Poster | 2.71 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.